ArticleHeliyon2024
Coexistence of DIPNECH with pulmonary adenocarcinoma: Coincidence or by design?
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) coexisting with pulmonary adenocarcinoma (ADC) is rare. Herein, we report a new case and review the cases published previously in the English literature. The clinicopathological features of similar cases reported in the English literature were summarized, and a putative association between DIPNECH and pulmonary ADC was suggested. Among the 22 cases studied, the majority of patients were female and older adults. DIPNECH lesions were usually recognized beyond the lobe or segment in which the ADC was located. Most ADCs were of a low- or intermediate-grade. DIPNECH and pulmonary ADC were interspersed in six patients. In particular, two cases of ADC showed neuroendocrine differentiation. We consider that DIPNECH accompanied by ADC is not coincidental, and that the two lesions may have a causal relationship. Analogous to the tumor histogenesis association of large cell neuroendocrine carcinoma/small cell carcinoma with ADC, we hypothesized that DIPNECH may also arise from a multipotent precursor cell and associate with a subgroup of ADC. However, further studies are required to explore this possibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.